Analysis of Demographic Associations and Survival Outcomes in Patients With Colorectal Cancer at a Tertiary Care Hospital in Pakistan. A Retrospective Cross-Sectional Study [0.03%]
巴基斯坦一家三级护理医院结直肠癌患者的 demographics 状况及生存结局分析：一项回顾性横断面研究
Muhammad Osama,Hira Moosa,Hussain Sohail Rangwala et al.
Muhammad Osama et al.
IntroductionColorectal cancer (CRC) is the third most common cancer worldwide, with higher rates in industrialized countries. By 2030, the number of CRC cases may rise by 60%, reaching 2.2 million new cases and 1.1 million deaths. In 2020, ...
Response to Letter to the Editor on "Correlation between irAEs and survival outcomes in patients with ES-SCLC treated with first-line chemoimmunotherapy" [0.03%]
致论著《一线化疗免疫治疗诱导的ES-SCLC患者的irAE与生存结局的相关性》作者信的回复
Federico Monaca,Igor Gomez-Randulfe,Raffaele Califano
Federico Monaca
Letter Re: Correlation between irAEs and survival outcomes in patients with ES-SCLC treated with first-line chemoimmunotherapy [0.03%]
关于化疗免疫治疗的一线疗效中不可逆性内分泌不良反应与生存结果相关性的信件
Taha Koray Sahin,Deniz Can Guven
Taha Koray Sahin
Predicting Survival Outcomes in Patients with Hepatocellular Carcinoma Receiving Lenvatinib by Using the Up7-ALBI Score [0.03%]
使用Up7-ALBI评分预测肝细胞癌患者接受仑伐替尼治疗的生存结局
Chien-Hung Lu,Wei-Yu Kao,Chih-Horng Wu et al.
Chien-Hung Lu et al.
Introduction: Lenvatinib effectively manages unresectable hepatocellular carcinoma (HCC). Current prognostic models do not integrate tumor burden with liver function. By combining the Up-to-7 criteria and the albumin-bili...
Survival Outcomes and Predictive Factors of Mortality in Feline Epilepsy: A Comprehensive Retrospective Study [0.03%]
猫癫痫的生存结果及死亡预测因素的全面回顾性研究
Kreevith Prompinichpong,Nirut Suwanna,Vachira Hunprasit et al.
Kreevith Prompinichpong et al.
Epilepsy is the most common neurological disorder in cats. However, information on the long-term outcomes and predictive survival factors based on neurological and clinicopathological findings is limited. We aimed to evaluate the clinical m...
Impact of Tumor Location on Survival Outcomes in Pancreatic Head Versus Body/Tail Cancer: Institutional Experience [0.03%]
胰头癌与胰体/尾癌肿瘤位置对生存结局的影响：机构经验
Abdullah Esmail,Vikram Dhillon,Ebtesam Al-Najjar et al.
Abdullah Esmail et al.
Background: Pancreatic ductal adenocarcinoma (PDAC) exhibits variable survival outcomes based on tumor location, with pancreatic head cancer (PHC) and pancreatic body/tail cancer (PBTC) differing in prognosis and treatment response. This st...
Impact of preoperative prognostic factors on survival outcomes in intrahepatic cholangiocarcinoma: a retrospective cohort study [0.03%]
术前预后因素对肝内胆管癌生存结局影响的回顾性队列研究
Hyun Jeong Jeon,So Jeong Yoon,Ho Chang Chae et al.
Hyun Jeong Jeon et al.
Purpose: This study assesses preoperative prognostic factors in intrahepatic cholangiocarcinoma (ICC) to improve risk assessment and inform clinical decisions, focusing on the role of lymph node dissection (LND). ...
Clinical effect of ePRO-based symptom monitoring and management on improving survival outcomes in patients with advanced cancer: a single-centre, prospective, randomised controlled trial protocol [0.03%]
基于ePRO的癌症晚期患者症状监测和管理改善生存结局的临床疗效：单中心前瞻性随机对照试验方案
Lili Tang,Yi He,Ying Pang et al.
Lili Tang et al.
Introduction: Symptom management is crucial in cancer care, yet patient symptoms are often overlooked in routine care. There is some evidence that electronic symptom monitoring and management can improve patients' physica...
Association Between Body Mass Index and Survival Outcomes for In-Hospital Cardiac Arrest [0.03%]
体重指数与院内心脏骤停生存结果的关系
Nobuhiro Ikemura,John A Spertus,Yoon Joo Cho et al.
Nobuhiro Ikemura et al.
Background: Body mass index (BMI), a key clinical marker, may influence outcomes after in-hospital cardiac arrest (IHCA), but its association with neurologically favorable survival remains unclear. ...
Proton pump inhibitors reduce survival outcomes in patients treated with capecitabine: meta-analysis [0.03%]
质子泵抑制剂可降低卡培他滨的疗效并影响生存期：荟萃分析研究
Dina Mohyeldeen,Waleed Arafat
Dina Mohyeldeen
Proton pump inhibitors (PPIs) are widely used over-the-counter drugs. The interaction between capecitabine and PPIs is still ambiguous within the literature, with some discrepancies still being present regarding the risks, or benefits, of t...
耗时 0.18846 秒，为您在
48229835
条记录里面共找到 4242 篇文章 [XML]